Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/20/06 | 10QSB | Optional form for quarterly and transition reports of small business issuers |
|
20 | |
| 01/17/06 | DEF 14A | Definitive proxy statements |
|
16 | |
| 01/17/06 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 01/06/06 | 8-K/A | Current report filing |
|
7 | |
| 01/04/06 | 8-K | Current report filing |
|
7 | |
| 11/08/05 | 8-K | Current report filing |
|
2 | |
| 10/14/05 | 10QSB | Optional form for quarterly and transition reports of small business issuers |
|
22 | |
| 09/09/05 | 10KSB | Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405] |
|
47 | |
| 09/07/05 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/29/05 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 |